首页> 外文期刊>Analytical methods >Diatomaceous earth supported liquid extraction and LC-MS/MS determination of elvitegravir and ritonavir in rat plasma: application to a pharmacokinetic study
【24h】

Diatomaceous earth supported liquid extraction and LC-MS/MS determination of elvitegravir and ritonavir in rat plasma: application to a pharmacokinetic study

机译:硅藻土支持的液体萃取和大鼠血浆中艾维格韦和利托那韦的LC-MS / MS测定:在药代动力学研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

A rapid, sensitive and selective bio-analytical method was developed for determination of elvitegravir and ritonavir in rat plasma by high-performance liquid chromatography-tandem mass spectrometry. Sample preparation was based on diatomaceous earth supported liquid extraction using dichioromethane to extract elvitegravir and ritonavir from rat plasma. Chromatographic separation was performed on a Waters Symmetry C_(18) column (4.6 x 250 mm, 5 urn) using 20 mM ammonium formate containing 0.05% trifluoroacetic acid and acetonitrile (35:65 v/v) for isocratic elution and mass detection. Calibration curves were linear with regression coefficients greater than 0.997 over the concentration range of 2-5000 ng mL~(-1) for elvitegravir and ritonavir. Absolute mean recoveries were in the range of 87.31 to 92.18% and no significant interferences were observed at the retention times of the elvitegravir, ritonavir and internal standard. The method exhibited good intra-and inter-day performance in terms of 1.55-7.47% precision and 0-5% accuracy. The developed method has been successfully applied to the pharmacokinetic study of elvitegravir in healthy rats following a single oral administration of a 15 mg kg~(-1) dose boosted with 5 mg kg~(-1) ritonavir.
机译:建立了一种快速,灵敏,选择性的生物分析方法,通过高效液相色谱-串联质谱法测定大鼠血浆中的依维戈韦和利托那韦。样品制备基于硅藻土支持的液体萃取,使用双氯甲烷从大鼠血浆中提取elvitegravir和ritonavir。色谱分离在Waters Symmetry C_(18)色谱柱(4.6 x 250 mm,5)上进行,使用20 mM甲酸铵(含0.05%三氟乙酸)和乙腈(35:65 v / v)进行等度洗脱和质量检测。依维替韦和利托那韦在2-5000 ng mL〜(-1)的浓度范围内,校准曲线呈线性,回归系数大于0.997。绝对平均回收率在87.31至92.18%的范围内,在elvitegravir,ritonavir和内标物的保留时间未观察到明显的干扰。该方法在1.55-7.47%的精度和0-5%的精度方面表现出良好的日内和日间性能。该方法已成功应用于elvitegravir在健康大鼠的药代动力学研究中,该药单次口服给予15 mg kg〜(-1)剂量的ritonavir增强剂量为15 mg kg〜(-1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号